97例のびまん性大細胞型B細胞リンパ腫におけるNational Comprehensive Cancer Network(NCCN) International Prognostic Indexの有用性についての後方視野的検討
Retrospective analysis of 97 cases of difffuse large B cell lymphoma using the National Comprehensive Cancer Network (NCCN) International Prognostic Index
The International Non-Hodgkin's Lymphoma Prognostic Factors Project: A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med 329, 987-994, 1993.
Habermann TM, Weller EA, Morrison VA, et al.: Rituximab-CHOP versus CHOP alone or with maintenance rituximab in older patients with diffuse large B-cell lymphoma. J Clin Oncol 24, 3121-3127, 2006.
Pfreundschuh M, Trümper L, Osterborg A, et al.: CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group. Lancet Oncol 7, 379-391, 2006.